Last Updated: 01/12/09
James W. Jacobson, Ph.D.
Acting Associate Director
Cancer Diagnosis Program
Dr. James W. Jacobson, Ph.D., has been the Acting Associate Director of the Cancer Diagnosis Program (CDP) since July 2008. He is also Chief of the CDP Diagnostic Biomarkers and Technology Branch, where he is responsible for developing and overseeing grants to identify and evaluate biomarkers that may aid physicians in making clinical management decisions for cancer patients and grants supporting the development of technologies for evaluation of molecular alterations in tumors. Dr. Jacobson leads the Strategic Partnering to Evaluate Cancer Signatures (SPECS) program and is a member of the Steering Committee of the Program for the Assessment of Clinical Cancer Tests (PACCT), which is developing strategies to move biomarkers into clinical practice.
Dr. Jacobson joined CDP in 1991 after more than a decade in industry at Genex Corp. He holds two patents. He received his undergraduate degree in biology from Dartmouth College and his doctoral degree in molecular biology from University of Utah.
